WILSON TROY EDWARD
SEC CIK 1589597 · EDGAR
BoughtSold
Most active insiders at PBYI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AUERBACH ALAN H | Pres, CEO, Dir, 10% | — | $568.9K |
| 2 | Cesano Alessandra | Dir | — | $567.0K |
| 3 | Senderowicz Adrian | Dir | — | $194.3K |
| 4 | MOYES JAY M | Dir | — | $158.8K |
| 5 | NOUGUES MAXIMO F | CFO | — | $141.7K |
| 6 | WILSON TROY EDWARD | Dir | — | $123.2K |
| 7 | HUNT DOUGLAS M | See Remarks | — | $122.6K |
| 8 | MILLER MICHAEL PATRICK | Dir | — | $97.2K |
| 9 | Dorval Allison | Dir | — | $83.6K |
| 10 | Stuglik Brian M | Dir | — | $58.3K |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 21:13 | 2026-09-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | S - Sale | $9.10 | -5,000 | 54.8K | -8% | -$45.5K |
| I | 2026-08-24 17:30 | 2026-08-24 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | P - Purchase | $12.39 | +100.0K | 479.2K | +26% | +$1.24M |
| I | 2026-08-17 16:45 | 2026-08-17 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | P - Purchase | $11.12 | +100.0K | 379.2K | +36% | +$1.11M |
| T | 2026-06-15 20:16 | 2026-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | A - Grant | $0.00 | +27.0K | 70.5K | +62% | $0 |
| T | 2026-06-15 20:16 | 2026-06-12 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | S - Sale | $7.20 | -10.8K | 59.8K | -15% | -$77.7K |
| D | 2026-03-25 | 2026-03-23 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | M - OptEx | $6.15 | +6,103 | 435.5K | +1% | +$37.5K |
| 2025-11-14 | 2025-11-13 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | A - Grant | $0.00 | +182.5K | 429.4K | +74% | $0 | |
| 2025-09-29 | 2025-09-27 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | A - Grant | $0.00 | +182.5K | 283.5K | +181% | $0 | |
| 2025-09-29 | 2025-09-29 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | S - Sale | $8.94 | -36.6K | 246.9K | -13% | -$327.3K | |
| 2025-09-09 | 2025-09-08 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | P - Purchase | $8.20 | +50.0K | 101.0K | +98% | +$410.0K | |
| M | 2025-08-14 | 2025-08-12+ | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | P - Purchase | $6.06 | +50.0K | 51.0K | +5,165% | +$303.2K |
| 2025-06-17 | 2025-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | S - Sale | $3.40 | -10.8K | 43.5K | -20% | -$36.7K | |
| 2025-06-13 | 2025-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | A - Grant | $0.00 | +27.0K | 54.4K | +99% | $0 | |
| 2024-06-21 | 2024-06-18 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | A - Grant | $0.00 | +27.0K | 27.4K | +7,714% | $0 | |
| 2024-06-17 | 2024-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | S - Sale | $3.33 | -27.0K | 350 | -99% | -$89.9K | |
| M | 2024-01-26 | 2024-01-24 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | M - OptEx | $6.05 | +91.1K | 7,504 | New | +$550.6K |
| M | 2024-01-26 | 2024-01-24 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | S - Sale+OE | $20.23 | -91.1K | 559 | -99% | -$1.84M |
| I | 2023-12-11 | 2023-12-07 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | G - Gift | $0.00 | -1,000 | 279.2K | -0.4% | $0 |
| 2023-12-11 | 2023-12-07 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | G - Gift | $0.00 | -2,000 | 559 | -78% | $0 | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | A - Grant | $0.00 | +27.0K | 27.4K | +7,714% | $0 | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | S - Sale | $3.45 | -27.0K | 350 | -99% | -$93.2K | |
| MI | 2023-06-02 | 2023-06-02 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | J - Other | $0.00 | -553.8K | 0 | -100% | $0 |
| 2023-06-02 | 2023-06-02 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | J - Other | $0.00 | -28.0K | 2,559 | -92% | $0 | |
| DMI | 2023-02-21 | 2022-07-14+ | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | J - Other | $0.00 | -486.0K | 1.15M | -30% | $0 |
| D | 2023-02-21 | 2022-08-19 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | Pres, CEO, Dir | J - Other | $0.00 | -12.0K | 30.5K | -28% | $0 |
| 2022-06-21 | 2022-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | S - Sale | $2.58 | -27.9K | 27.4K | -50% | -$71.9K | |
| 2022-06-16 | 2022-06-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Dir | A - Grant | $0.00 | +27.0K | 55.2K | +96% | $0 |
Purchase Sale Sale after option exercise All abbreviations